Cuin a bhios Alnylam Pharmaceuticals, Inc. a 'foillseachadh aithris prothaid is call?
Tha aithris prothaid is call Alnylam Pharmaceuticals, Inc. air fhoillseachadh aon uair sa cheathramh; chaidh an aithisg mu dheireadh de thoraidhean ionmhais Alnylam Pharmaceuticals, Inc. fhoillseachadh air 31/03/2021.
Dè a 'phrothaid bho na h-earrannan de Alnylam Pharmaceuticals, Inc.?
B 'e tuairmse de chosnaidhean gach roinn de Alnylam Pharmaceuticals, Inc. -1.71 $ anns an aithisg ionmhais mu dheireadh.
Cuin a dh'fhoillsicheas Alnylam Pharmaceuticals, Inc. an ath aithris prothaid agus call?
Bidh an ath aithisg air a 'chunntas prothaid is call Alnylam Pharmaceuticals, Inc. air An t-Ògmhios 2024.
Alnylam Pharmaceuticals, Inc. cosnadh gach cuibhreann - feartan ionmhais a ’chompanaidh a rèir meud a luach. Tha buannachdan gach cuibhreann air an tomhas a rèir na foirmle: tha an ìre de phrothaid a ’chompanaidh airson na h-ùine ionmhais a rèir aithisgean oifigeil air a roinn leis an àireamh de earrannan sa chompanaidh. Tha e soilleir gu bheil cosnadh Alnylam Pharmaceuticals, Inc. gach roinn na fheart ionmhasail airson ùine sònraichte. Prothaid Alnylam Pharmaceuticals, Inc. - prothaid iomlan a ’chompanaidh san ùine aithris.
|
Brabac Alnylam Pharmaceuticals, Inc.
Tha Alnylam Pharmaceuticals, Inc. prothaid iomlan airson iomradh a-mhàin agus chan eil e inntinneach do luchd-earrannan fa leth. Nas cudromaiche tha obrachadh a-mach gach cuibhreann. Tha an luach seo mar bhunait airson a bhith a ’tomhas earrannan agus tha iarrtas nas motha ann bho aire luchd-earrannan. Tha ceann-latha na h-aithisg prothaid Alnylam Pharmaceuticals, Inc. air a shuidheachadh le riaghladh na buidhne. Tha cinn-latha aithrisean prothaid Alnylam Pharmaceuticals, Inc. airson amannan o chionn ghoirid air an sealltainn ann an clàr agus graf na seirbheis air-loidhne againn.
|
Prothaid ràitheil Alnylam Pharmaceuticals, Inc.
Cosnadh gach cuibhreann Alnylam Pharmaceuticals, Inc. air a thomhas a rèir na foirmle: teachd-a-steach lom air a roinn leis an àireamh iomlan de earrannan sa chompanaidh. Thathas a ’beachdachadh air buannachdan gach cuibhreann de Alnylam Pharmaceuticals, Inc. airson ùine ionmhais sònraichte a bharrachd air aithisgean ionmhais mu phrothaid iomlan a’ chompanaidh air an toirt seachad. Gheibhear Alnylam Pharmaceuticals, Inc. cosnadh gach cuibhreann airson na h-ùine aithris mu dheireadh anns a ’chlàr againn (an t-sreath as àirde) no graf (an colbh as fhaide air falbh). Is e prothaid ràitheil Alnylam Pharmaceuticals, Inc. an seòrsa aithisg ionmhais as cumanta airson anailisean ionmhais.
|
|
Ceann-là aithisg ALNY
|
Tuarastal airson gach roinn
Tha tuarastalan gach co-roinn air an tomhas le bhith a 'roinneadh teachd-a-steach (no prothaid) lìon le àireamh nan earrannan den chompanaidh.
|
Atharrachadh airson na bliadhna %
|
|
31/03/2021 |
-1.71 USD |
- |
|
31/12/2020 |
-2.09 USD |
-15.385% ↓ |
|
30/09/2020 |
-2.18 USD |
+13.54% ↑ |
|
30/06/2020 |
-1.56 USD |
-22.772% ↓ |
|
31/12/2019 |
-2.47 USD |
-0.36% ↓ |
|
30/09/2019 |
-1.92 USD |
-2.626% ↓ |
|
30/06/2019 |
-2.02 USD |
-5.645% ↓ |
|
31/03/2019 |
-1.73 USD |
-29.134% ↓ |
|
31/12/2018 |
-2.09 USD |
-37.258% ↓ |
|
30/09/2018 |
-2.43 USD |
-36.475% ↓ |
|
30/06/2018 |
-1.83 USD |
-30.377% ↓ |
|
31/03/2018 |
-1.41 USD |
-14.162% ↓ |
|
31/12/2017 |
-1.48 USD |
-3.836% ↓ |
|
30/09/2017 |
-1.34 USD |
-9.842% ↓ |
|
30/06/2017 |
-1.34 USD |
-1.534% ↓ |
|
31/03/2017 |
-1.25 USD |
-16.532% ↓ |
|
31/12/2016 |
-1.32 USD |
-28.394% ↓ |
|
30/09/2016 |
-1.21 USD |
-19.647% ↓ |
|
30/06/2016 |
-1.05 USD |
-40% ↓ |
|
31/03/2016 |
-1.21 USD |
-37.678% ↓ |
|
31/12/2015 |
-1.07 USD |
-37.348% ↓ |
|
30/09/2015 |
-0.91 USD |
-30.902% ↓ |
|
30/06/2015 |
-0.85 USD |
-26.399% ↓ |
|
31/03/2015 |
-0.62 USD |
-17.939% ↓ |
|
31/12/2014 |
-0.28 USD |
-24.843% ↓ |
|
30/09/2014 |
-0.58 USD |
-38.712% ↓ |
|
30/06/2014 |
-0.58 USD |
-36.739% ↓ |
|
31/03/2014 |
-0.39 USD |
-46.579% ↓ |
|
31/12/2013 |
-0.51 USD |
-68.458% ↓ |
|
30/09/2013 |
-0.48 USD |
-19.926% ↓ |
|
30/06/2013 |
-0.29 USD |
-44.472% ↓ |
|
31/03/2013 |
-0.16 USD |
-20.239% ↓ |
|
31/12/2012 |
-0.46 USD |
-77.259% ↓ |
|
30/09/2012 |
-0.38 USD |
-11.744% ↓ |
|
30/06/2012 |
-0.25 USD |
-46.528% ↓ |
|
31/03/2012 |
-0.25 USD |
-17.461% ↓ |
|
31/12/2011 |
-0.33 USD |
-7.96% ↓ |
|
30/09/2011 |
-0.31 USD |
-12.733% ↓ |
|
30/06/2011 |
-0.33 USD |
-16.975% ↓ |
|
31/03/2011 |
-0.38 USD |
-0.953% ↓ |
|
31/12/2010 |
-0.16 USD |
-15.603% ↓ |
|
30/09/2010 |
-0.23 USD |
-41.615% ↓ |
|
30/06/2010 |
-0.35 USD |
-39.002% ↓ |
|
31/03/2010 |
-0.29 USD |
-22.857% ↓ |
|
31/12/2009 |
-0.19 USD |
-48.619% ↓ |
|
30/09/2009 |
-0.22 USD |
-27.128% ↓ |
|
30/06/2009 |
-0.55 USD |
-68.708% ↓ |
|
31/03/2009 |
-0.19 USD |
-39.507% ↓ |
|
31/12/2008 |
-0.23 USD |
-30.867% ↓ |
|
30/09/2008 |
-0.07 USD |
-82.96% ↓ |
|
30/06/2008 |
-0.31 USD |
-36.444% ↓ |
|
31/03/2008 |
-0.03 USD |
-50.296% ↓ |
|
31/12/2007 |
0.04 USD |
-26.568% ↓ |
|
30/09/2007 |
-1.35 USD |
-67.662% ↓ |
|
30/06/2007 |
-0.34 USD |
-14.711% ↓ |
|
31/03/2007 |
-0.58 USD |
-28.691% ↓ |
|
31/12/2006 |
-0.26 USD |
-39.17% ↓ |
|
30/09/2006 |
-0.23 USD |
-5.339% ↓ |
|
30/06/2006 |
-0.31 USD |
-20.694% ↓ |
|
31/03/2006 |
-0.3 USD |
-17.722% ↓ |
|
31/12/2005 |
-0.56 USD |
-56.903% ↓ |
|
30/09/2005 |
-0.51 USD |
-5.937% ↓ |
|
30/06/2005 |
-0.54 USD |
-38.505% ↓ |
|
31/03/2005 |
-0.32 USD |
- |
|
31/12/2004 |
-0.29 USD |
- |
|
30/09/2004 |
-0.33 USD |
- |
|
30/06/2004 |
-1.1 USD |
- |
Tha Alnylam Pharmaceuticals, Inc. cosnadh gach ràithe mar thomhas de phrothaid na companaidh. Ach tha nas lugha de dh'iarrtas ann na prothaid na bliadhna air aon roinn. Is e a ’phrothaid ràitheil mu dheireadh Alnylam Pharmaceuticals, Inc. an-diugh a’ phrothaid a chaidh ainmeachadh gu h-oifigeil airson a ’cheathramh iomraidh mu dheireadh. Tha atharrachadh ann an prothaid Alnylam Pharmaceuticals, Inc. airson na bliadhna na luach àireamhaichte airson fiosrachadh a bharrachd a tha a ’sealltainn an atharrachadh sa cheud de phrothaid leis an aon eadar-ama den bhliadhna mu dheireadh. Tha an atharrachadh ann am prothaid ràitheil de Alnylam Pharmaceuticals, Inc. na luach nach eil cho mòr an coimeas ris an atharrachadh ann am prothaid bliadhnail Alnylam Pharmaceuticals, Inc..
Airson goireasachd tuigse agus anailis, bidh sinn a ’foillseachadh an atharrachaidh ann am prothaid mar cheudad. Tha eachdraidh prothaid Alnylam Pharmaceuticals, Inc. airson na bliadhnaichean a dh ’fhalbh agus amannan aithris anns a’ chlàr “Prothaid ràitheil”. Alnylam Pharmaceuticals, Inc. tha eachdraidh cosnaidh ràitheil ri fhaighinn air-loidhne airson gach bliadhna agus cairteal thairis air na deich bliadhna a dh ’fhalbh. Tha Alnylam Pharmaceuticals, Inc. stòr-dàta prothaid air-loidhne airson amannan ùine air a chur ri chèile bho stòran oifigeil dearbhte fad na h-ùine.
|
